CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) (USD $)	3 Months Ended		6 Months Ended
	Jan. 31, 2015	Jan. 31, 2014	Jan. 31, 2015	Jul. 31, 2014
Operating Expenses:
Research and development	$ 222,384	$ 213,599	$ 630,680	$ 749,773
General and administrative	612,763	797,262	1,112,936	1,704,139
Total Operating Expenses	835,147	1,010,861	1,743,616	2,453,912
Operating Loss	(835,147)	(1,010,861)	(1,743,616)	(2,453,912)
Other Income (Expense):
Income from assets held for investment, net (Note 10)				193,607
Interest income	2	23	11	46
Interest expense	(85,468)	(67,608)	(167,202)	(165,380)
Change in fair value of derivative liabilities (Note 9)	408,697	(2,107,844)	1,120,675	(230,557)
Gain on extinguishment of debt (Note 5)			327,839
Net Loss (Note 4)	(511,916)	(3,186,290)	(462,293)	(2,656,196)
Preferred Stock Dividend (Note 8)		408,279		408,279
Net Loss Available to Common Stockholders	$ (511,916)	$ (3,594,569)	$ (462,293)	$ (3,064,475)
Net Loss per Common Share (Note 7) - Basic	$ (0.001)	$ (0.006)	$ (0.001)	$ (0.005)
Net Loss per Common Share (Note 7) - Diluted	$ (0.001)	$ (0.006)	$ (0.001)	$ (0.005)
Basic Shares Used to Compute Earnings per Share (Note 7)	789,848,649	627,522,138	784,906,679	611,449,549
Diluted Shares Used to Compute Earnings/(Loss) per Share (Note 7)	789,848,649	627,522,138	784,906,679	611,449,549